PLOS ONE, ISSN 1932-6203, 08/2019, Volume 14, Issue 8, p. e0221231
Treatment guidelines differ in their recommendation to determine baseline resistance associated substitutions (RAS) before starting a first-line treatment with...
HCV GENOTYPE | VIRUS-INFECTION | REAL-LIFE | SUBTYPES | ANTIVIRAL DRUGS | MULTIDISCIPLINARY SCIENCES | Treatment outcome | Analysis | Dosage and administration | Research | Hepatitis C | Drug therapy | Drug resistance | Ribavirin | Prevalence studies (Epidemiology) | Effectiveness | Liver diseases | Infections | Hepatitis | Genotype & phenotype | Infectious diseases | Hepatology | Gastroenterology | Hepatitis C virus | Genotypes
HCV GENOTYPE | VIRUS-INFECTION | REAL-LIFE | SUBTYPES | ANTIVIRAL DRUGS | MULTIDISCIPLINARY SCIENCES | Treatment outcome | Analysis | Dosage and administration | Research | Hepatitis C | Drug therapy | Drug resistance | Ribavirin | Prevalence studies (Epidemiology) | Effectiveness | Liver diseases | Infections | Hepatitis | Genotype & phenotype | Infectious diseases | Hepatology | Gastroenterology | Hepatitis C virus | Genotypes
Journal Article
2001, ISBN 9780820450995, 347
Book
European Journal of Internal Medicine, ISSN 0953-6205, 06/2019, Volume 64, pp. 63 - 71
The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson...
Charlson index | Comorbidity | Surgery | Age | Endocarditis | CRITERIA | DIAGNOSIS | PROSTHETIC VALVE ENDOCARDITIS | MANAGEMENT | OLD | CO-MORBIDITY | MEDICINE, GENERAL & INTERNAL | INDEX | ELDERLY-PATIENTS | EPIDEMIOLOGY | Patient outcomes | Mortality
Charlson index | Comorbidity | Surgery | Age | Endocarditis | CRITERIA | DIAGNOSIS | PROSTHETIC VALVE ENDOCARDITIS | MANAGEMENT | OLD | CO-MORBIDITY | MEDICINE, GENERAL & INTERNAL | INDEX | ELDERLY-PATIENTS | EPIDEMIOLOGY | Patient outcomes | Mortality
Journal Article
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, ISSN 0305-7453, 06/2019, Volume 74, Issue 6, pp. 1713 - 1717
Objectives: Tropheryma whipplei has been detected in 3.5% of the blood culture-negative cases of endocarditis in Spain. Experience in the management of T....
DIAGNOSIS | INFECTIOUS DISEASES | TRIMETHOPRIM | RESISTANCE | TRIMETHOPRIM/SULFAMETHOXAZOLE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTIVE ENDOCARDITIS
DIAGNOSIS | INFECTIOUS DISEASES | TRIMETHOPRIM | RESISTANCE | TRIMETHOPRIM/SULFAMETHOXAZOLE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTIVE ENDOCARDITIS
Journal Article
The Journal of Rheumatology, ISSN 0315-162X, 10/2009, Volume 36, Issue 10, pp. 2204 - 2211
Objective. Aortic pulse wave velocity (PWV) is an independent predictor of risk for atherosclerotic cardiovascular disease. Metabolic syndrome (MetS) is more...
Pulse wave velocity | Insulin resistance | Systemic lupus erythematosus | Metabolic syndrome | Atherosclerosis | RHEUMATOID-ARTHRITIS | HOMOCYSTEINE | METABOLIC SYNDROME | INSULIN RESISTANCE | PULSE-WAVE VELOCITY | ATHEROSCLEROSIS | RISK | PREVALENCE | RHEUMATOLOGY | PULSE WAVE VELOCITY | WOMEN | SYSTEMIC LUPUS ERYTHEMATOSUS | INSULIN-RESISTANCE | INFLAMMATION | CARDIOVASCULAR-DISEASE | CORONARY-HEART-DISEASE | Lupus Erythematosus, Systemic - complications | Humans | Middle Aged | Male | Elasticity - physiology | Young Adult | Atherosclerosis - etiology | C-Reactive Protein - metabolism | Insulin Resistance - physiology | Interleukin-6 - blood | Metabolic Syndrome - physiopathology | Adult | Female | Blood Pressure - physiology | Aorta - physiopathology | Cross-Sectional Studies | Atherosclerosis - physiopathology | Logistic Models | Biomarkers - blood | Metabolic Syndrome - complications | Arteries - physiopathology | Adolescent | Aged | Lupus Erythematosus, Systemic - physiopathology | Blood Flow Velocity - physiology | Cohort Studies
Pulse wave velocity | Insulin resistance | Systemic lupus erythematosus | Metabolic syndrome | Atherosclerosis | RHEUMATOID-ARTHRITIS | HOMOCYSTEINE | METABOLIC SYNDROME | INSULIN RESISTANCE | PULSE-WAVE VELOCITY | ATHEROSCLEROSIS | RISK | PREVALENCE | RHEUMATOLOGY | PULSE WAVE VELOCITY | WOMEN | SYSTEMIC LUPUS ERYTHEMATOSUS | INSULIN-RESISTANCE | INFLAMMATION | CARDIOVASCULAR-DISEASE | CORONARY-HEART-DISEASE | Lupus Erythematosus, Systemic - complications | Humans | Middle Aged | Male | Elasticity - physiology | Young Adult | Atherosclerosis - etiology | C-Reactive Protein - metabolism | Insulin Resistance - physiology | Interleukin-6 - blood | Metabolic Syndrome - physiopathology | Adult | Female | Blood Pressure - physiology | Aorta - physiopathology | Cross-Sectional Studies | Atherosclerosis - physiopathology | Logistic Models | Biomarkers - blood | Metabolic Syndrome - complications | Arteries - physiopathology | Adolescent | Aged | Lupus Erythematosus, Systemic - physiopathology | Blood Flow Velocity - physiology | Cohort Studies
Journal Article
General Thoracic and Cardiovascular Surgery, ISSN 1863-6705, 7/2019, Volume 67, Issue 7, pp. 585 - 593
Infective endocarditis (IE) still carries high morbidity and mortality and frequently requires surgery. The benefit of mitral valve repair (MVr) in the setting...
Medicine & Public Health | Cardiac Surgery | Mitral valve reparation | Thoracic Surgery | Cardiology | Surgical Oncology | Infectious endocarditis | Mitral valve replacement | Cardiac surgery | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT
Medicine & Public Health | Cardiac Surgery | Mitral valve reparation | Thoracic Surgery | Cardiology | Surgical Oncology | Infectious endocarditis | Mitral valve replacement | Cardiac surgery | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT
Journal Article
2001
Book
Clinical Infectious Diseases, ISSN 1058-4838, 5/2013, Volume 56, Issue 9, pp. 1261 - 1268
Background. The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for...
Enterococcus faecalis | Health outcomes | Relapse | Kidney failure | Infectious diseases | Antimicrobials | Endocarditis | Aminoglycosides | Infections | ARTICLES AND COMMENTARIES | Heart valves | gentamicin | ampicillin plus ceftriaxone | infective endocarditis | outcome | DIAGNOSIS | INFECTIOUS DISEASES | AMINOGLYCOSIDES | MANAGEMENT | EFFICACY | PROGNOSIS | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | RESISTANT | THERAPY | ASSOCIATION | Enterococcus faecalis - drug effects | Humans | Middle Aged | Male | Ampicillin - administration & dosage | Gentamicins - administration & dosage | Young Adult | Endocarditis - microbiology | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Adult | Ceftriaxone - administration & dosage | Female | Treatment Outcome | Spain | Enterococcus faecalis - isolation & purification | Drug Therapy, Combination - methods | Hospitals | Adolescent | Italy | Aged | Endocarditis - drug therapy | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Cohort Studies | Drugs | Dose-response relationship (Biochemistry) | Ampicillin | Gentamicin | Infective endocarditis | Ceftriaxone sodium | Dosage and administration | Product/Service Evaluations | Ceftriaxone | Drug therapy
Enterococcus faecalis | Health outcomes | Relapse | Kidney failure | Infectious diseases | Antimicrobials | Endocarditis | Aminoglycosides | Infections | ARTICLES AND COMMENTARIES | Heart valves | gentamicin | ampicillin plus ceftriaxone | infective endocarditis | outcome | DIAGNOSIS | INFECTIOUS DISEASES | AMINOGLYCOSIDES | MANAGEMENT | EFFICACY | PROGNOSIS | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | RESISTANT | THERAPY | ASSOCIATION | Enterococcus faecalis - drug effects | Humans | Middle Aged | Male | Ampicillin - administration & dosage | Gentamicins - administration & dosage | Young Adult | Endocarditis - microbiology | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Adult | Ceftriaxone - administration & dosage | Female | Treatment Outcome | Spain | Enterococcus faecalis - isolation & purification | Drug Therapy, Combination - methods | Hospitals | Adolescent | Italy | Aged | Endocarditis - drug therapy | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Cohort Studies | Drugs | Dose-response relationship (Biochemistry) | Ampicillin | Gentamicin | Infective endocarditis | Ceftriaxone sodium | Dosage and administration | Product/Service Evaluations | Ceftriaxone | Drug therapy
Journal Article
MEDICINE, ISSN 0025-7974, 08/2019, Volume 98, Issue 32, p. e16813
Dolutegravir (DTG) has shown effectiveness in combination with rilpivirine in with experience of antiretroviral therapy (ART) and with 3TC in naive patients...
TRIPLE TREATMENT | EMTRICITABINE | OPEN-LABEL | dolutegravir | REGIMENS | NON-INFERIORITY | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | DOLAMA | TENOFOVIR DISOPROXIL FUMARATE | RITONAVIR PLUS LAMIVUDINE | dual therapy | INFECTION | INHIBITOR | HIV-1 | Heterocyclic Compounds, 3-Ring - economics | Anti-HIV Agents - economics | Fees, Pharmaceutical - statistics & numerical data | Lamivudine - administration & dosage | Humans | Middle Aged | Male | Viral Load | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Economics, Pharmaceutical | Anti-HIV Agents - adverse effects | CD4 Lymphocyte Count | Cost-Benefit Analysis | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Lamivudine - economics | Medical research | Medicine, Experimental | Lamivudine | HIV patients | Dosage and administration | Drug therapy | HIV infection | Health aspects
TRIPLE TREATMENT | EMTRICITABINE | OPEN-LABEL | dolutegravir | REGIMENS | NON-INFERIORITY | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | DOLAMA | TENOFOVIR DISOPROXIL FUMARATE | RITONAVIR PLUS LAMIVUDINE | dual therapy | INFECTION | INHIBITOR | HIV-1 | Heterocyclic Compounds, 3-Ring - economics | Anti-HIV Agents - economics | Fees, Pharmaceutical - statistics & numerical data | Lamivudine - administration & dosage | Humans | Middle Aged | Male | Viral Load | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Economics, Pharmaceutical | Anti-HIV Agents - adverse effects | CD4 Lymphocyte Count | Cost-Benefit Analysis | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Lamivudine - economics | Medical research | Medicine, Experimental | Lamivudine | HIV patients | Dosage and administration | Drug therapy | HIV infection | Health aspects
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2015, Volume 61, Issue 10, pp. 1582 - 1589
OBJECTIVE: To describe the pharmacokinetics of maraviroc in human immunodeficiency virus (HIV)-infected women during pregnancy and post partum. METHODS:...
pharmacokinetics | maraviroc | HIV | MTCT | pregnancy | INFECTIOUS DISEASES | TRANSMISSION | MICROBIOLOGY | IMMUNOLOGY | EXPOSURE | Triazoles - administration & dosage | Blood Chemical Analysis | United States | Europe | Humans | Cyclohexanes - administration & dosage | Anti-HIV Agents - administration & dosage | Pregnancy | Young Adult | Maraviroc | Anti-HIV Agents - pharmacokinetics | Pregnancy Complications, Infectious - drug therapy | Adult | Female | HIV Infections - drug therapy | Triazoles - pharmacokinetics | Cyclohexanes - pharmacokinetics | Care and treatment | Usage | Pregnant women | Clinical trials | Dosage and administration | HIV infection | Health aspects | Index Medicus | AIDS
pharmacokinetics | maraviroc | HIV | MTCT | pregnancy | INFECTIOUS DISEASES | TRANSMISSION | MICROBIOLOGY | IMMUNOLOGY | EXPOSURE | Triazoles - administration & dosage | Blood Chemical Analysis | United States | Europe | Humans | Cyclohexanes - administration & dosage | Anti-HIV Agents - administration & dosage | Pregnancy | Young Adult | Maraviroc | Anti-HIV Agents - pharmacokinetics | Pregnancy Complications, Infectious - drug therapy | Adult | Female | HIV Infections - drug therapy | Triazoles - pharmacokinetics | Cyclohexanes - pharmacokinetics | Care and treatment | Usage | Pregnant women | Clinical trials | Dosage and administration | HIV infection | Health aspects | Index Medicus | AIDS
Journal Article
Endoscopy, ISSN 0013-726X, 10/2013, Volume 45, Issue 11
Journal Article
Circulation, ISSN 0009-7322, 06/2013, Volume 127, Issue 23, pp. 2272 - 2284
Background- The purpose of this study was to assess the incidence of neurological complications in patients with infective endocarditis, the risk factors for...
Infection | Endocardium | Nervous system | Complications | infection | INTERNATIONAL-COLLABORATION | CARDIAC & CARDIOVASCULAR SYSTEMS | complications | EMBOLIZATION | STROKE | nervous system | VEGETATION SIZE | THERAPY | CEREBROVASCULAR COMPLICATIONS | endocardium | VALVE-REPLACEMENT | PERIPHERAL VASCULAR DISEASE | EMBOLIC EVENTS | ECHOCARDIOGRAPHY | EPIDEMIOLOGY | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Postoperative Complications - mortality | Meningitis - etiology | Staphylococcal Infections - complications | Incidence | Brain Abscess - epidemiology | Ultrasonography | Adult | Female | Retrospective Studies | Endocarditis - complications | Cerebral Hemorrhage - etiology | Brain Ischemia - epidemiology | Cerebral Hemorrhage - chemically induced | Multicenter Studies as Topic - statistics & numerical data | Encephalitis - epidemiology | Comorbidity | Risk Factors | Proportional Hazards Models | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Treatment Outcome | Combined Modality Therapy | Intracranial Aneurysm - epidemiology | Brain Ischemia - etiology | Endocarditis - epidemiology | Anticoagulants - adverse effects | Meningitis - epidemiology | Heart Valve Prosthesis Implantation - statistics & numerical data | Intracranial Aneurysm - etiology | Staphylococcal Infections - epidemiology | Cerebral Hemorrhage - epidemiology | Spain - epidemiology | Brain Abscess - etiology | Aged | Endocarditis - diagnostic imaging | Endocarditis - drug therapy | Encephalitis - etiology | Endocarditis - surgery | Heart | Complications and side effects | Neurologic manifestations of general diseases | Care and treatment | Usage | Patient outcomes | Surgery | Infective endocarditis | Risk factors
Infection | Endocardium | Nervous system | Complications | infection | INTERNATIONAL-COLLABORATION | CARDIAC & CARDIOVASCULAR SYSTEMS | complications | EMBOLIZATION | STROKE | nervous system | VEGETATION SIZE | THERAPY | CEREBROVASCULAR COMPLICATIONS | endocardium | VALVE-REPLACEMENT | PERIPHERAL VASCULAR DISEASE | EMBOLIC EVENTS | ECHOCARDIOGRAPHY | EPIDEMIOLOGY | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Postoperative Complications - mortality | Meningitis - etiology | Staphylococcal Infections - complications | Incidence | Brain Abscess - epidemiology | Ultrasonography | Adult | Female | Retrospective Studies | Endocarditis - complications | Cerebral Hemorrhage - etiology | Brain Ischemia - epidemiology | Cerebral Hemorrhage - chemically induced | Multicenter Studies as Topic - statistics & numerical data | Encephalitis - epidemiology | Comorbidity | Risk Factors | Proportional Hazards Models | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Treatment Outcome | Combined Modality Therapy | Intracranial Aneurysm - epidemiology | Brain Ischemia - etiology | Endocarditis - epidemiology | Anticoagulants - adverse effects | Meningitis - epidemiology | Heart Valve Prosthesis Implantation - statistics & numerical data | Intracranial Aneurysm - etiology | Staphylococcal Infections - epidemiology | Cerebral Hemorrhage - epidemiology | Spain - epidemiology | Brain Abscess - etiology | Aged | Endocarditis - diagnostic imaging | Endocarditis - drug therapy | Encephalitis - etiology | Endocarditis - surgery | Heart | Complications and side effects | Neurologic manifestations of general diseases | Care and treatment | Usage | Patient outcomes | Surgery | Infective endocarditis | Risk factors
Journal Article
Lupus, ISSN 0961-2033, 4/2010, Volume 19, Issue 5, pp. 591 - 598
The objective of this article was to evaluate whether serum uric acid (SUA) correlates with arterial stiffness and inflammation markers in a cohort of women...
Systemic lupus erythematosus | Uric acid | Arterial stiffness | Atherosclerosis | arterial stiffness | atherosclerosis | MORTALITY | METABOLIC SYNDROME | WAVE VELOCITY-MEASUREMENT | RISK | CELL-PROLIFERATION | RHEUMATOLOGY | INSULIN | HOMOCYSTEINE LEVELS | systemic lupus erythematosus | uric acid | PLASMA HOMOCYSTEINE | ASSOCIATION | DAMAGE INDEX | Atherosclerosis - etiology | Lupus Erythematosus, Systemic - complications | Cross-Sectional Studies | Lupus Erythematosus, Systemic - urine | Arteries - physiopathology | Humans | Middle Aged | Adult | Female | Uric Acid - blood | Lupus Erythematosus, Systemic - physiopathology | Lupus | Creatinine | Femur | C-reactive protein | Kidneys | Cardiovascular disease | Regression analysis | Metabolism | Velocity | Cholesterol | Womens health | Arteriosclerosis | Fibrinogen | Renal failure | Cardiovascular diseases | Health risk assessment | Homocysteine | Metabolic disorders | Kidney transplantation
Systemic lupus erythematosus | Uric acid | Arterial stiffness | Atherosclerosis | arterial stiffness | atherosclerosis | MORTALITY | METABOLIC SYNDROME | WAVE VELOCITY-MEASUREMENT | RISK | CELL-PROLIFERATION | RHEUMATOLOGY | INSULIN | HOMOCYSTEINE LEVELS | systemic lupus erythematosus | uric acid | PLASMA HOMOCYSTEINE | ASSOCIATION | DAMAGE INDEX | Atherosclerosis - etiology | Lupus Erythematosus, Systemic - complications | Cross-Sectional Studies | Lupus Erythematosus, Systemic - urine | Arteries - physiopathology | Humans | Middle Aged | Adult | Female | Uric Acid - blood | Lupus Erythematosus, Systemic - physiopathology | Lupus | Creatinine | Femur | C-reactive protein | Kidneys | Cardiovascular disease | Regression analysis | Metabolism | Velocity | Cholesterol | Womens health | Arteriosclerosis | Fibrinogen | Renal failure | Cardiovascular diseases | Health risk assessment | Homocysteine | Metabolic disorders | Kidney transplantation
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 12/2018, Volume 273, pp. 193 - 198
Pericardial effusion is a frequent finding in the setting of infective endocarditis. Limited data exists on clinical characteristics and outcomes in this group...
Heart failure | Echocardiography | Prognosis | Endocarditis | Pericardial effusion | MORTALITY | SURGERY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | HEART-FAILURE | ASSOCIATION | Prospective Studies | Follow-Up Studies | Pericardial Effusion - mortality | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Mortality - trends | Endocarditis, Bacterial - diagnostic imaging | Spain - epidemiology | Pericardial Effusion - diagnostic imaging | Aged, 80 and over | Heart Valve Diseases - mortality | Adult | Female | Aged | Cohort Studies | Heart Valve Diseases - diagnostic imaging | Infective endocarditis | Valves | Risk factors
Heart failure | Echocardiography | Prognosis | Endocarditis | Pericardial effusion | MORTALITY | SURGERY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | HEART-FAILURE | ASSOCIATION | Prospective Studies | Follow-Up Studies | Pericardial Effusion - mortality | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Mortality - trends | Endocarditis, Bacterial - diagnostic imaging | Spain - epidemiology | Pericardial Effusion - diagnostic imaging | Aged, 80 and over | Heart Valve Diseases - mortality | Adult | Female | Aged | Cohort Studies | Heart Valve Diseases - diagnostic imaging | Infective endocarditis | Valves | Risk factors
Journal Article
MEDICINA CLINICA, ISSN 0025-7753, 07/2019, Volume 153, Issue 2, pp. 63 - 66
Introduction: a description of infective left endocarditis at the turn of the millennium. Method: A multicentre prospective study into the left endocarditis...
SURGERY | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | Mortality | Nosocomial | Infective endocarditis | Epidemiology
SURGERY | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | Mortality | Nosocomial | Infective endocarditis | Epidemiology
Journal Article
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, ISSN 0213-005X, 11/2018, Volume 36, Issue 9, pp. 555 - 562
Introduction: Anal cancer is one of the most common non-AIDS defining malignancies, especially in men who have sex with men and women living with HIV (WLHIV)....
INFECTIOUS DISEASES | RISK-FACTORS | Anal cancer | Women living with HIV | Anal cancer precursor lesions | TERMINOLOGY | AIDS | MICROBIOLOGY | CERVICAL-CANCER | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | ACTIVE ANTIRETROVIRAL THERAPY | MEN | COHORT | High-risk human papillomavirus | Cervical cancer | HUMAN-PAPILLOMAVIRUS INFECTION
INFECTIOUS DISEASES | RISK-FACTORS | Anal cancer | Women living with HIV | Anal cancer precursor lesions | TERMINOLOGY | AIDS | MICROBIOLOGY | CERVICAL-CANCER | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | ACTIVE ANTIRETROVIRAL THERAPY | MEN | COHORT | High-risk human papillomavirus | Cervical cancer | HUMAN-PAPILLOMAVIRUS INFECTION
Journal Article
Medicine (United States), ISSN 0025-7974, 09/2017, Volume 96, Issue 39, p. e8109
Squamous cell carcinoma of anus (SCCA) is one of the most frequent non-AIDS-defining diseases in HIV patients, mainly in men who have sex with men (MSM), and...
HIV | high-risk human papillomavirus | men who have sex with men | squamous cell carcinoma of anus | HSIL | SEX | TERMINOLOGY | CYTOLOGY | PREVALENCE | LESIONS | MEDICINE, GENERAL & INTERNAL | ANAL CANCER | MEN | COHORT | PENILE | Multivariate Analysis | Prevalence | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Anus Neoplasms - virology | Male | Anal Canal - virology | Papillomaviridae - genetics | Homosexuality, Male | Adult | Papillomavirus Infections - virology | Endoscopy, Gastrointestinal - methods | Anus Neoplasms - epidemiology | Oncogenes | Anti-Retroviral Agents - therapeutic use | Papillomavirus Infections - complications | Carcinoma, Squamous Cell - epidemiology | HIV Infections - virology | Risk Factors | Genotype | Logistic Models | HIV Infections - complications | Papillomavirus Infections - drug therapy | Human papillomavirus 16 - genetics
HIV | high-risk human papillomavirus | men who have sex with men | squamous cell carcinoma of anus | HSIL | SEX | TERMINOLOGY | CYTOLOGY | PREVALENCE | LESIONS | MEDICINE, GENERAL & INTERNAL | ANAL CANCER | MEN | COHORT | PENILE | Multivariate Analysis | Prevalence | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Anus Neoplasms - virology | Male | Anal Canal - virology | Papillomaviridae - genetics | Homosexuality, Male | Adult | Papillomavirus Infections - virology | Endoscopy, Gastrointestinal - methods | Anus Neoplasms - epidemiology | Oncogenes | Anti-Retroviral Agents - therapeutic use | Papillomavirus Infections - complications | Carcinoma, Squamous Cell - epidemiology | HIV Infections - virology | Risk Factors | Genotype | Logistic Models | HIV Infections - complications | Papillomavirus Infections - drug therapy | Human papillomavirus 16 - genetics
Journal Article